Drug Trial Radar · NCT05163808
A Randomized Study of BPN14770 in Male Adolescents (Aged 9 to < 18 Years) With Fragile X Syndrome
Last checked: Nov 19, 2026Latest source record: Aug 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
163
Actual
Start
Mar 29, 2022
Primary completion
Sep 2, 2025
Study completion Sep 2, 2025
Sponsor
- Lead sponsor
- Tetra Discovery PartnersIndustry
- Sponsor type
- Industry
- First posted
- Dec 20, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 9 years, up to 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a 2-part study, with each part having a unique set of objectives for male adolescents aged 9 to \< 18 years with fragile X syndrome (FXS). Part 1 is an open-label, single-dose, pharmacokinetics (PK) assessment of BPN14770 25 mg and 50 mg, while Part 2 is double-blind (DB) and randomized between two treatment groups (Study Drug and Placebo).
Conditions
- Fragile X Syndrome
Interventions
zatolmilastDrug
Subjects will receive a 15 mg or 25 mg dose of zatolmilast (BPN14770) or placebo
PlaceboDrug
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- NIH Toolbox Cognitive Battery cognition crystallized composite scoreTime frame: 13 Weeks
Locations
17 sites in 1 country. Site status is shown where the registry gives one.
Amnova Clinical Research
Irvine, California
Thompson Autism & Neurodevelopment Center - CHOC
Orange, California
UC Davis
Sacramento, California
Children's Hospital Colorado
Aurora, Colorado
University of Miami
Miami, Florida
Emory University School of Medicine
Atlanta, Georgia
Rush University Medical Center
Chicago, Illinois
University of Kansas Medical Center
Kansas City, Kansas
Kennedy Krieger Institute
Baltimore, Maryland
Boston Children's Hospital
Boston, Massachusetts
U Mass
Worcester, Massachusetts
Icahn School of Medicine at Mount Sinai Hospital
New York, New York
Cincinatti Children's Hospital Medical Center
Cincinnati, Ohio
Suburban Research Associates
Media, Pennsylvania
Clinic for Special Children
Strasburg, Pennsylvania
Greenwood Genetic Center
Greenville, South Carolina
University of Utah and Primary Childrens Hospital
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.